Broadwood Partners, L.P.'s Form 4 filing
Lineage Cell Therapeutics, Inc. (LCTX) · filed Feb 8, 2024
- Accession no.
- 0000919574-24-000757
- Filed
- Feb 8, 2024, 6:58 PM ET
- Trade date
- Feb 6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $7.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadwood Partners, L.P.CIK 0001278386 | Director, 10% Owner |
| Bradsher Neal CCIK 0001278388 | Director, 10% Owner |
| Broadwood Capital IncCIK 0001278387 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Shares | PPurchaseAcquired | +6,730,770 | $1.04 | +$7,000,000.8 | 41,666,255 | Direct | |
| Feb 6, 2024 | Common Shares | PPurchaseAcquired | 0 | $0.00 | $0 | 41,666,255 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.